Huang William A, Wassie Maereg A, Ajijola Olujimi A
UCLA Cardiac Arrhythmia Center, University of California, Los Angeles, CA, USA.
UCLA Neurocardiology Research Center, David Geffen School of Medicine at UCLA, 100 Medical Plaza, Suite 660, Westwood Blvd, Los Angeles, CA, 90095-1679, USA.
Curr Treat Options Cardiovasc Med. 2018 Mar 6;20(3):23. doi: 10.1007/s11936-018-0616-0.
His bundle pacing (HBP) has been shown to be a feasible, beneficial, and safe way to achieve cardiac resynchronization therapy (CRT) with recruitment of the heart's physiological conduction system. HBP should be considered for those with unfavorable coronary sinus (CS) anatomy, and nonresponders to biventricular (BiV) pacing. HBP CRT may also help patients with the nonleft bundle branch block form of conduction delay and heart failure (HF). HBP CRT should be considered strongly in preventing right ventricular (RV) pacing-induced cardiomyopathy, especially after atrioventricular nodal ablation given the discrete nature of the block and the low likelihood of distal block. With increased operator experience and improved lead delivery systems, HBP success rates and safety have improved and are comparable to traditional RV pacing. Battery longevity is also likely comparable to traditional BiV CRT devices. We anticipate the use of HBP CRT growing significantly.
希氏束起搏（HBP）已被证明是一种可行、有益且安全的方法，可通过募集心脏的生理传导系统来实现心脏再同步治疗（CRT）。对于那些冠状窦（CS）解剖结构不佳以及双心室（BiV）起搏无反应者，应考虑采用HBP。HBP CRT也可能有助于患有非左束支传导阻滞形式的传导延迟和心力衰竭（HF）的患者。在预防右心室（RV）起搏诱发的心肌病方面，应强烈考虑HBP CRT，特别是在房室结消融术后，鉴于阻滞的离散性质和远端阻滞的低可能性。随着术者经验的增加和导线输送系统的改进，HBP的成功率和安全性有所提高，与传统RV起搏相当。电池寿命也可能与传统BiV CRT设备相当。我们预计HBP CRT的使用将显著增加。
